Biotech SF
San Francisco Bay Area biotech stories.
Thursday, May 5, 2011
Maxygen swings to profit in Q1
Maxygen Inc. on Thursday reported first quarter net income of $1.5 million, or 5 cents a share, compared to a loss in the same period last year of $2 million, or 6 cents a share.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment